Atacand HCT and Ibritumomab Intravenous
Determining the interaction of Atacand HCT and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: candesartan / hydrochlorothiazide
Brand name: Atacand HCT
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atacand HCT-Ibritumomab Tiuxetan
- Atacand HCT-Ibrutinib
- Atacand HCT-Ibrutinib Capsules
- Atacand HCT-Ibrutinib Tablets
- Atacand HCT-Ibu
- Atacand HCT-IBU Tablets
- Ibritumomab Intravenous-Atarax
- Ibritumomab Intravenous-Atarax (Hydroxyzine Capsules and Tablets)
- Ibritumomab Intravenous-Atarax (Hydroxyzine Syrup)
- Ibritumomab Intravenous-Atasol
- Ibritumomab Intravenous-Atazanavir
- Ibritumomab Intravenous-Atazanavir and cobicistat